FREMONT, Calif., July 20, 2016 /PRNewswire/ -- Velos recently integrated the Velos eResearch clinical trial management system (CTMS) and the Enroll® e-Consenting tablet application by Mytrus at the University of Alabama at Birmingham (UAB). The cutting-edge interface allows patient consent, data and documents from multiple sites to automatically flow from Enroll into Velos eResearch.
"The interface takes the UAB initiative to use more "direct-to-participant" methods one step further," said Jeffrey Curtis, M.D., William J. Koopman professor of medicine in the UAB Division of Clinical Immunology and Rheumatology. "Patient data entered in Enroll automatically syncs with the Velos eResearch electronic data capture trial management system, reducing the need for double data entry. The integrated solution will serve as a model for other research institutions that want to secure patient engagement while streamlining clinical trial management processes and giving the participant a better enrollment experience."
Velos is the industry leading provider of clinical research management solutions and continues to make rapid advances in technology and break new ground to bridge the gap between clinical research and point of care. Velos eResearch is designed with industry standards, scalability and interoperability in mind, facilitating communication between different systems and sites using the system for recruitment and study management.
"Even as responses are registered in the Enroll application, data gets pulled into Velos eResearch where patients are randomized and assigned to appropriate calendars and treatment arms," said Priti Sahai, M.D., senior vice president of Velos. "The result is seamless workflow, saving time and reducing the cost of a clinical trial."
Mytrus' Enroll platform is used globally by industry leaders to support clinical research trials, disease registries, and biosample collection, providing patients and volunteers with a secure method to learn about what their participation will entail. Independent studies have confirmed that Enroll increases participant comprehension of the risks and benefits, their rights and responsibilities, and the key information they need to make an informed decision and provide a regulatory compliant electronic informed consent.
Velos is the trusted clinical trial management resource for investigators, sponsors, and academic leaders throughout the world. Velos integrates the clinical, administrative and financial information needs of research management, with an emphasis on flexibility and workflow and empowering clinical innovation. Founded in 1996, Velos, Inc. is privately held with headquarters in Fremont, California. For more information, visit www.velos.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/new-technology-bridges-the-gap-of-clinical-studies-and-patient-care-300301588.html